Studies have shown that metformin inhibits the invasion and metastasis of tumor cells and induces degradation of cyclin D1 through AMP-activated protein kinase/glycogen synthase kinase 3 beta (AMPK/GSK3β) signaling axis to participate in the protein ubiquitination process [40]. The gene discussed is CCND1; the disease is neoplasm.